Oral respiratory vaccine
AssigneeIntervet Inc.
InventorsRhonda L. LaFleur, Jennifer C. Dant, Ian Tarpey, Zhichang Xu
Life of this patent
Estimating the term…
Abstract
The present invention is drawn to new oral live canine parainfluenza virus vaccines and related multivalent vaccines. Methods of using the vaccine alone or in combination with one or more other protective immunogens in multivalent vaccines are also provided.
Claims10
An oral bivalent vaccine for providing effective protection to a canine from upper respiratory diseases and infectious tracheobronchitis, the oral bivalent vaccine consisting essentially of a modified live canine parainfluenza (CPI) virus and an avirulent live Bordetella bronchiseptica (B. bronchiseptica) and optionally an adjuvant, and wherein the oral bivalent vaccine is formulated for oral administration.
Dependencies are inferred from the claim text.